Biodegradable polyurethanes for implants. II. In vitro degradation and calcification of materials from poly(epsilon-caprolactone)-poly(ethylene oxide) diols and various chain extenders.

Linear, biodegradable, aliphatic polyurethanes with various degrees of hydrophilicity were synthesized in bulk at 50-100 degrees C. The ratios between the hydrophilic and hydrophobic segments were 0:100, 30:70, 40:60, 50:50, and 70:30, respectively. The hydrophilic segment consisted of poly(ethylene oxide) (PEO) diol (molecular weight = 600 or 2000) or the poly(ethylene-propylene-ethylene oxide) (PEO-PPO-PEO) diol Pluronic F-68 (molecular weight = 8000). The hydrophobic segment was made of poly(epsilon-caprolactone) diol (molecular weight = 530, 1250, or 2000). The chain extenders were 1,4-butane diol and 2-amino-1-butanol. The diisocyanate was aliphatic hexamethylene diisocyanate. The polymers absorbed water in an amount that increased with the increasing content of the PEO segment in the polymer chain. The total amount of absorbed water did not exceed 2% for the poly(ester urethane)s and was as high as 212% for some poly(ester ether urethane)s that behaved in water like hydrogels. The polymers were subjected to in vitro degradation at 37 +/- 0.1 degrees C in phosphate buffer solutions for up to 76 weeks. The poly(ester urethane)s showed 1-2% mass loss at 48 weeks and 1.1-3.8% mass loss at 76 weeks. The poly(ester ether urethane)s manifested 1.6-76% mass loss at 48 weeks and 1.6-96% mass loss at 76 weeks. The increasing content and molecular weight of the PEO segment enhanced the rate of mass loss. Similar relations were also observed for polyurethanes from PEO-PPO-PEO (Pluronic) diols. Materials obtained with 2-amino-1-butanol as the chain extender degraded at a slower rate than similar materials synthesized with 1,4-butane diol. All the materials already manifested a progressive decrease in the molecular weight in the first month of in vitro aging. The rate of molecular weight loss was higher for poly(ester ether urethane)s than for poly(ester urethane)s. For poly(ester ether urethane)s, the rate of molecular weight loss was higher for materials containing Pluronic than for those containing PEO segments. All polymers calcified in vitro. The susceptibility to calcification increased with material hydrophilicity. The progressive deposition of calcium salt on the film surfaces resulted in the formation of large crystal aggregates, the structure of which depended on the chemical composition of the calcified material. Needle-like aggregates, resembling brushite, formed on the hydrophobic polyurethane, and plate-like crystals formed on the highly hydrophilic material. The calcium-to-phosphorus atomic ratio of the crystals growing on the samples was dependent on the chemical composition of the material and varied from 0.94 to 1.55.

[1]  A. Takahara,et al.  Effect of soft segment chemistry on the biostability of segmented polyurethanes. II. In vitro hydrolytic degradation and lipid sorption. , 1992, Journal of biomedical materials research.

[2]  F. E. Critchfield,et al.  Thermoplastic urethane elastomers. II. Effects of variations in hard-segment concentration , 1975 .

[3]  D J Wheatley,et al.  Polyurethane heart valves: fatigue failure, calcification, and polyurethane structure. , 1997, Journal of biomedical materials research.

[4]  James P. Braselton,et al.  Technology and Applications , 1997 .

[5]  S. Gogolewski,et al.  Novel Biodegradable Polyurethanes for Medical Applications , 2000 .

[6]  M. Okada,et al.  Polyaddition of saccharic dilactones with hexamethylene diisocyanate , 1993 .

[7]  K. Hashimoto,et al.  Synthesis of polyurethanes from saccharide-derived diols and diisocyanates and their hydrolyzability , 1996 .

[8]  J. Tanaka,et al.  Apatite formation on organic monolayers in simulated body environment. , 2000, Journal of biomedical materials research.

[9]  J. Seppälä,et al.  The modification of lactic acid based poly(ester-urethane) by copolymerization , 1997 .

[10]  Z. Gu,et al.  The Synthesis of Biodegradable Polymers with Functional Side Chains , 1987 .

[11]  S. Gogolewski Selected topics in biomedical polyurethanes. A review , 1989 .

[12]  M. Sisido,et al.  Synthesis of polyetherurethanes containing L-serine dipeptide and their use as materials for biomedical films. , 1985, Biomaterials.

[13]  J. Tanaka,et al.  Hydroxyapatite formation on cellulose cloth induced by citric acid , 2000, Journal of materials science. Materials in medicine.

[14]  A. Takahara,et al.  Effect of soft segment chemistry on the biostability of segmented polyurethanes. I. In vitro oxidation. , 1991, Journal of biomedical materials research.

[15]  T. Umemura,et al.  Degradation of polyetherurethane by subcutaneous implantation into rats. II. Changes of contact angles, infrared spectra, and nuclear magnetic resonance spectra. , 1995, Journal of biomedical materials research.

[16]  P. Neuenschwander,et al.  Development of degradable polyesterurethanes for medical applications: in vitro and in vivo evaluations. , 1997, Journal of biomedical materials research.

[17]  F. Tan,et al.  Ionic Interactions of Polyurethanes , 1988, Journal of biomaterials applications.

[18]  V. Shilov,et al.  Supermolecular organization of some polyurethanes containing sugar derivatives in the main chain , 1984 .

[19]  James M. Anderson,et al.  Polyurethane Elastomer Biostability , 1995, Journal of biomaterials applications.

[20]  K. Mauritz,et al.  Bioabsorbable composites. II: Nontoxic, L-lysine-based poly(ester-urethane) matrix composites , 1993 .

[21]  R Guidoin,et al.  Assessing the resistance to calcification of polyurethane membranes used in the manufacture of ventricles for a totally implantable artificial heart. , 1999, Journal of biomedical materials research.

[22]  D. C. Hoffman,et al.  Hydroxy‐terminated poly(ε‐caprolactone‐co‐δ‐valerolactone) oligomers: Synthesis, characterization, and polyurethane network formation , 1991 .

[23]  S. Gogolewski,et al.  BIODEGRADABLE MATERIALS OF POLYLACTIDES, .4. POROUS BIOMEDICAL MATERIALS BASED ON MIXTURES OF POLYLACTIDES AND POLYURETHANES , 1982 .

[24]  C. G. Pitt,et al.  Modification of the rates of chain cleavage of poly(ϵ-caprolactone) and related polyesters in the solid state , 1987 .

[25]  J. Gardette,et al.  Infrared analysis of the photochemical behaviour of segmented polyurethanes : 1. Aliphatic poly(ester-urethane) , 1997 .

[26]  E. Ruckenstein,et al.  Solvent-stimulated surface rearrangement of polyurethanes , 1990 .

[27]  D. Han,et al.  In vivo biostability and calcification-resistance of surface-modified PU-PEO-SO3. , 1993, Journal of biomedical materials research.

[28]  R. J. Thoma Poly(ether) Urethane Reactivity with Metal-Ion in Calcification and Environmental Stress Cracking , 1986, Journal of biomaterials applications.

[29]  G. Golomb Calcification of polyurethane-based biomaterials implanted subcutaneously in rats: role of porosity and fluid absorption in the mechanism of mineralization , 1992 .

[30]  Coleman Dl Mineralization of blood pump bladders. , 1981 .

[31]  A. J. Pennings,et al.  DESIGN AND SYNTHESIS OF BIODEGRADABLE POLY(ESTER-URETHANE) ELASTOMER NETWORKS COMPOSED OF NON-TOXIC BUILDING-BLOCKS , 1988 .

[32]  M. Okada,et al.  Hydrolysis and release behavior of hydrolyzable poly(etherurethane) gels derived from saccharide‐, L‐lysine‐derivatives, and poly(propylene glycol) , 1997 .

[33]  T. Alfrey Mechanical behavior of high polymers , 1948 .

[34]  Y. Imanishi,et al.  Effect of thermal treatment on the structure and the biomedical properties of polyetherurethane film containing dipeptides of L-serine. , 1985, Biomaterials.

[35]  R. Aitken,et al.  Thermoplastic polyurethane elastomers based on aliphatic diisocyanates: thermal transitions , 1977 .

[36]  S. Gogolewski Liquid-induced crystallization and annealing of polyester-urethane elastomers , 1978 .

[37]  T. Yamamuro,et al.  Apatite coated on organic polymers by biomimetic process: improvement in adhesion to substrate by HCl treatment , 1995 .

[38]  V. Shilov,et al.  Structural peculiarities of block copolyurethanes with peptide links as rigid block extenders. , 1983, Biomaterials.

[39]  F. E. Critchfield,et al.  Thermoplastic urethane elastomers. VI. Dilute solution properties in various solvents , 1980 .

[40]  R. Storey,et al.  Hydrolyzable poly (ester-urethane) networks from L-lysine diisocyanate and D,L-lactide/ε-caprolactone homo- and copolyester triols , 1994 .

[41]  J. Andrade,et al.  Calcification of nontextured implantable blood pumps. , 1981, Transactions - American Society for Artificial Internal Organs.

[42]  K. Woodhouse,et al.  Synthesis and characterization of degradable polyurethane elastomers containing and amino acid-based chain extender. , 1998, Journal of biomaterials science. Polymer edition.

[43]  S. Cooper,et al.  Effect of polyol molecular weight on the physical properties and haemocompatibility of polyurethanes containing polyethylene oxide macroglycols. , 1994, Biomaterials.

[44]  G. Golomb,et al.  Development of a new in vitro model for studying implantable polyurethane calcification. , 1991, Biomaterials.

[45]  A. Hiltner,et al.  Biodegradation of a polyurethane in vitro. , 1987, Journal of biomedical materials research.